Figure 2.

Symptoms and modified Rankin Scale (mRS) scores at presentation, 3 months, 1 year, and 2 years in 19 cases of LE. Seizures and use of ASM at onset, 1 week, 1 month, 3 months, 6 months, and final follow‐up in 25 cases. (A) Each radial segment represents one patient, arranged clockwise from youngest to oldest. Patients <12‐years‐old are shown in the section with white background, and those ≥12‐years‐old in the section with gray background. (B) mRS scores at each timepoint are shown in the middle figure. Each line represents one patient. The proportion with each mRS score at each timepoint is displayed. Six patients had not reached the 2‐year follow‐up. (C) Seizure occurrence and ASM in all 25 patients at each timepoint are shown in the bottom figure. Arrows demonstrate number of cases with change in seizure occurrence and use of ASM over the first 6 months and at final follow‐up (range 6–108 months). One patient that died had seizures requiring PICU admission prior to death. This is reported as seizures at final‐follow‐up. This figure created for the purposes of this manuscript (with permission to reuse) by the following co‐authors: Michael Eyre, Saraswathy Sabanathan, and Ming Lim. LE, limbic encephalitis; PICU, pediatric intensive care unit; ASM, anti‐seizure medication.